0001209191-23-056071.txt : 20231120 0001209191-23-056071.hdr.sgml : 20231120 20231120163138 ACCESSION NUMBER: 0001209191-23-056071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231116 FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spaventa Andrew CENTRAL INDEX KEY: 0001859701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40443 FILM NUMBER: 231423202 MAIL ADDRESS: STREET 1: 10931 N. TORREY PINES ROAD, SUITE 100 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Singular Genomics Systems, Inc. CENTRAL INDEX KEY: 0001850906 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 812948451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-7830 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-16 0 0001850906 Singular Genomics Systems, Inc. OMIC 0001859701 Spaventa Andrew 3010 SCIENCE PARK ROAD SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-11-16 4 P 0 43468 0.4108 A 3986206 I By The Andrew K. Spaventa Living Trust dated April 9, 2014 Common Stock 2023-11-17 4 P 0 75000 0.4234 A 4061206 I By The Andrew K. Spaventa Living Trust dated April 9, 2014 Common Stock 9766 D The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.3770 to $0.4200, inclusive. The reporting person undertakes to provide to Singular Genomics Systems, Inc., any security holder of Singular Genomics Systems, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.4200 to $0.4456, inclusive. The reporting person undertakes to provide to Singular Genomics Systems, Inc., any security holder of Singular Genomics Systems, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Dalen Meeter, Attorney-in-Fact 2023-11-20